Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 11:15 am Purchase |
2024-09-30 | 13G | GT Biopharma, Inc. GTBP |
CYTOVANCE BIOLOGICS INC | 219,457 9.800% |
219,457 (New Position) |
Filing History |
| 2024-05-23 8:31 pm Purchase |
2024-05-23 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 190,000 8.800% |
179,162 (+1653.09%) |
Filing History |
| 2024-02-14 2:46 pm Purchase |
2023-12-31 | 13G | GT Biopharma, Inc. GTBP |
Armistice Capital, LLC | 2,175,358 4.990% |
2,175,358 (New Position) |
Filing History |
| 2023-09-19 11:56 am Purchase |
2023-06-30 | 13G | GT Biopharma, Inc. GTBP |
CYTOVANCE BIOLOGICS INC | 91,861 6.800% |
91,861 (New Position) |
Filing History |
| 2023-02-14 12:51 pm Purchase |
2022-12-31 | 13G | GT Biopharma, Inc. GTBP |
Armistice Capital, LLC | 122,540 9.990% |
122,540 (New Position) |
Filing History |
| 2022-03-02 9:28 pm Sale |
2022-02-28 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 10,838 1.060% |
-28,905 (-72.73%) |
Filing History |
| 2022-01-28 5:00 pm Sale |
2021-12-31 | 13G | GT Biopharma, Inc. GTBP |
BIGGER CAPITAL FUND L P | 0 0.000% |
-48,443 (Position Closed) |
Filing History |
| 2022-01-18 11:30 am Sale |
2021-12-31 | 13G | GT Biopharma, Inc. GTBP |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 8,841 0.867% |
-2,966 (-25.12%) |
Filing History |
| 2021-04-16 07:59 am Purchase |
2021-04-05 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 39,743 4.170% |
26,763 (+206.19%) |
Filing History |
| 2021-02-17 4:07 pm Purchase |
2021-02-11 | 13G | GT Biopharma, Inc. GTBP |
BIGGER CAPITAL FUND L P | 48,443 7.000% |
48,443 (New Position) |
Filing History |
| 2021-02-08 3:08 pm Unchanged |
2020-12-31 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 12,980 7.910% |
0 (Unchanged) |
Filing History |
| 2021-02-05 11:10 am Purchase |
2020-12-31 | 13G | GT Biopharma, Inc. GTBP |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 11,807 7.190% |
11,807 (New Position) |
Filing History |
| 2020-06-10 08:08 am Purchase |
2020-06-08 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 12,980 9.360% |
5,933 (+84.18%) |
Filing History |
| 2020-05-18 4:06 pm Purchase |
2020-05-15 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 7,047 5.080% |
1,132 (+19.14%) |
Filing History |